As of 2025-01-14, the Relative Valuation of Emergent BioSolutions Inc (EBS) is (63.97) USD. This relative valuation is based on P/E multiples. With the latest stock price at 9.41 USD, the upside of Emergent BioSolutions Inc based on Relative Valuation is -779.8%.
The range of the Relative Valuation is (56.27) - (67.83) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.6x - 17.6x | 16.1x |
| Forward P/E multiples | 14.5x - 19.7x | 17.1x |
| Fair Price | (56.27) - (67.83) | (63.97) |
| Upside | -697.9% - -820.8% | -779.8% |
| Date | P/E |
| 2025-01-08 | -2.62 |
| 2025-01-07 | -2.67 |
| 2025-01-06 | -2.66 |
| 2025-01-03 | -2.68 |
| 2025-01-02 | -2.66 |
| 2024-12-31 | -2.48 |
| 2024-12-30 | -2.40 |
| 2024-12-27 | -2.15 |
| 2024-12-26 | -2.18 |
| 2024-12-24 | -2.15 |
| 2024-12-23 | -2.11 |
| 2024-12-20 | -2.10 |
| 2024-12-19 | -2.09 |
| 2024-12-18 | -2.12 |
| 2024-12-17 | -2.28 |
| 2024-12-16 | -2.30 |
| 2024-12-13 | -2.20 |
| 2024-12-12 | -2.25 |
| 2024-12-11 | -2.22 |
| 2024-12-10 | -2.23 |
| 2024-12-09 | -2.27 |
| 2024-12-06 | -2.34 |
| 2024-12-05 | -2.37 |
| 2024-12-04 | -2.45 |
| 2024-12-03 | -2.41 |
| 2024-12-02 | -2.55 |
| 2024-11-29 | -2.63 |
| 2024-11-27 | -2.62 |
| 2024-11-26 | -2.60 |
| 2024-11-25 | -2.56 |
| 2024-11-22 | -2.46 |
| 2024-11-21 | -2.44 |
| 2024-11-20 | -2.30 |
| 2024-11-19 | -2.15 |
| 2024-11-18 | -2.23 |
| 2024-11-15 | -2.00 |
| 2024-11-14 | -2.41 |
| 2024-11-13 | -2.59 |
| 2024-11-12 | -2.83 |
| 2024-11-11 | -3.11 |
| 2024-11-08 | -3.05 |
| 2024-11-07 | -2.85 |
| 2024-11-06 | -2.39 |
| 2024-11-05 | -2.32 |
| 2024-11-04 | -2.28 |
| 2024-11-01 | -2.37 |
| 2024-10-31 | -2.35 |
| 2024-10-30 | -2.49 |
| 2024-10-29 | -2.42 |
| 2024-10-28 | -2.51 |